Peptide receptor radionuclide therapy in gastroenteropancreatic NEN G3: a multicenter cohort study

EA Carlsen, N Fazio, D Granberg… - Endocrine-related …, 2019 - erc.bioscientifica.com
Peptide receptor radionuclide therapy (PRRT) is an established treatment of metastatic
neuroendocrine tumors grade 1–2 (G1–G2). However, its possible benefit in high-grade …

Semiautomatic tumor delineation for evaluation of 64Cu-DOTATATE PET/CT in patients with neuroendocrine neoplasms: prognostication based on lowest lesion …

EA Carlsen, CB Johnbeck, M Loft… - Journal of Nuclear …, 2021 - Soc Nuclear Med
Patients with neuroendocrine neoplasms (NENs) have heterogeneous somatostatin
receptor expression, with highly differentiated lesions having higher expression. Receptor …

[HTML][HTML] A convolutional neural network for total tumor segmentation in [64Cu]Cu-DOTATATE PET/CT of patients with neuroendocrine neoplasms

EA Carlsen, K Lindholm, A Hindsholm, M Gæde… - EJNMMI research, 2022 - Springer
Background Segmentation of neuroendocrine neoplasms (NENs) in [ 64 Cu]Cu-DOTATATE
positron emission tomography makes it possible to extract quantitative measures useable …

64Cu-DOTATATE PET/CT and prediction of overall and progression-free survival in patients with neuroendocrine neoplasms

EA Carlsen, CB Johnbeck, T Binderup… - Journal of Nuclear …, 2020 - Soc Nuclear Med
Overexpression of somatostatin receptors (SSTRs) in patients with neuroendocrine neoplasms
(NENs) is used for both diagnosis and treatment. Receptor density may reflect tumor …

Prospective phase II trial of prognostication by 68Ga-NOTA-AE105 uPAR PET in patients with neuroendocrine neoplasms: implications for uPAR-targeted therapy

EA Carlsen, M Loft, A Loft, AK Berthelsen… - Journal of Nuclear …, 2022 - Soc Nuclear Med
The clinical course for patients with neuroendocrine neoplasms (NENs) ranges from indolent
to highly aggressive. Noninvasive tools to improve prognostication and guide decisions on …

[HTML][HTML] Diagnostic Value of Preoperative uPAR-PET/CT in Regional Lymph Node Staging of Oral and Oropharyngeal Squamous Cell Carcinoma: A Prospective …

…, K Juhl, G Lelkaitis, K Karnov, EA Carlsen… - Diagnostics, 2023 - mdpi.com
The detection of lymph node metastases is a major challenge in oral and oropharyngeal
squamous cell carcinoma (OSCC and OPSCC). Ga-NOTA-AE105 is a novel positron emission …

[HTML][HTML] First-in-Human Study of [68Ga]Ga-NODAGA-E[c(RGDyK)]2 PET for Integrin αvβ3 Imaging in Patients with Breast Cancer and Neuroendocrine Neoplasms …

MM Clausen, EA Carlsen, C Christensen, J Madsen… - Diagnostics, 2022 - mdpi.com
Arginine-Glycine-Aspartate (RGD)-recognizing cell surface integrins are involved in tumor
growth, invasiveness/metastases, and angiogenesis, and are therefore an attractive treatment …

Prospective phase II trial of [68Ga] Ga-NODAGA-E [c (RGDyK)] 2 PET/CT imaging of integrin αvβ3 for prognostication in patients with neuroendocrine neoplasms

EA Carlsen, M Loft, A Loft, D Czyzewska… - Journal of Nuclear …, 2023 - Soc Nuclear Med
Integrin α v β 3 , a subtype of the arginine-glycine-aspartate (RGD)–recognizing cell surface
integrins, is upregulated on endothelial cells during angiogenesis and on tumor cells. …

Spondylitis kompliceret med septiske embolier i lunger og muskulatur

MF Lønnee, EA Carlsen, P Hovind - Ugeskrift for Laeger, 2023 - content.ugeskriftet.dk
En 57-årig tidligere rask kvinde blev indlagt med ekstremitetssmerter og kraftnedsættelse
forudgået af rygsmerter efter et kort sygeforløb. Der var biokemiske tegn på infektion og akut …

[CITATION][C] Molecular imaging for prognostication of patients with neuroendocrine neoplasms

EA Carlsen - 2023 - research.regionh.dk
Esben Andreas Carlsen